BioSpace News Archive

Deals

Nuevolution Approved for Listing on Nasdaq Stockholm

Nasdaq Stockholm’s listing committee has approved that Nuevolution AB (publ)'s (“Nuevolution”) shares are admitted to trading on Nasdaq Stockholm’s main market.

June 14, 2018
·
3 min read
Business

Yasso® Frozen Greek Yogurt Announces The Game On! Foundation

Childhood Best Friends Turned Entrepreneurs Launch New Non-Profit Organization With Inaugural Community Event On The Greenway

June 14, 2018
·
4 min read
Biotech Beach

“Dateline NBC” Highlights Growing Interest in CBD

CBD Naturals® offers growing range of CBD-enhanced products

June 14, 2018
·
2 min read
Business

Two National Organizations Honor Five Members of Congress for Making Mental Health a Priority

Honorees: Rep. Napolitano (D-CA-32), Rep. Beyer (D-VA-08), Rep. DeGette (D-CO-01), Sen. Hatch (R-UT), Rep. Chris Stewart (R-UT-02)

June 14, 2018
·
3 min read
Business

Cross Country Healthcare’s Managed Services Program recognized as industry leader on HRO Today Baker’s Dozen

Cross Country Healthcare, Inc. is honored to be named to HRO Today’s Baker’s Dozen ratings list.

June 14, 2018
·
3 min read
Pure Encapsulations® launches PureResponse™, first-to-market platform to support conditions related to healthy immune balance and function

BOSTON, June 14, 2018 /PRNewswire/ -- Pure Encapsulations®, a leading manufacturer of research-based, hypoallergenic nutritional supplements, has launched PureResponseTM, a first-of-its-kind platform at the forefront of functional immunology.

June 14, 2018
·
3 min read
Biotech Bay

The Bonnie J. Addario Lung Cancer Foundation (ALCF) Earns 4-Star Rating from Charity Navigator

The sole lung cancer focused group to receive this rating

June 14, 2018
·
4 min read
BioCapital

Recovery Centers of America at Waldorf Upgrades Name to The Maryland Center for Addiction Treatment

The Elevated Name Reflects the Expanded Offerings of a Comprehensive Campus for Addiction Treatment

June 14, 2018
·
2 min read
Drug Development

Pharnext Announces PXT3003 was Granted Priority Review by the China Food and Drug Administration

Pharnext SA today announced that PXT3003 was granted priority review for Charcot-Marie-Tooth Type 1A disease (CMT1A) by the China Food and Drug Administration (CFDA).

June 14, 2018
·
3 min read
Business

EMOSIS Announces an Exclusive Distribution Agreement with 5-Diagnostics and the Start of Commercialization

Emosis starts selling HIT Confirm(R), Emosis’ first test, through 5-Diagnostics’ international network

June 14, 2018
·
2 min read